ITEMS IN AFP WITH KEYWORD:
Daily multivitamin supplementation results in a minimal, if any, reduction in epithelial cell cancers in men. This study found no significant benefit to multivitamin supplementation in reducing the risk of prostate, colorectal, lung, or bladder cancers. The risks of cancer-related mortality and all-...
Case Study: A 61-year-old black man presents for a routine checkup. He has hypertension and diabetes mellitus that are well controlled with medication. During the visit, he tells you that a friend advised him to get a prostate-specific antigen (PSA) test to screen for prostate cancer, and he would like to pursue testing.
Feb 15, 2013 Issue
Screening for Prostate Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)-based screening for prostate cancer.
Oct 15, 2012 Issue
Behavioral Counseling to Prevent Skin Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends counseling children, adolescents, and young adults 10 to 24 years of age who have fair skin about minimizing their exposure to ultraviolet (UV) radiation to reduce the risk of skin cancer.
Case study: A 17-year-old white female patient with dark hair comes to your office for a refill of her seasonal allergy prescription. Her primary residence is in Minnesota. She mentions that she heard that sun tanning was “bad for you” and asks whether it is true.
Photo Quiz presents readers with a clinical challenge based on a photograph or other image.
Selenium deficiency is associated with a higher risk of cancer, but selenium supplementation does not decrease that risk.
Feb 15, 2012 Issue
Screening for Bladder Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.
Dec 1, 2006 Issue
Opioids for Management of Breakthrough Pain in Cancer Patients [Cochrane for Clinicians]
Oral transmucosal fentanyl citrate (OTFC [Actiq]), a rapid-acting opioid, has been shown to be an effective treatment for breakthrough cancer pain. Other opioids, including immediate-release oral morphine (MSIR), also may be effective; however, evidence comparing these agents with OTFC is lacking.
Aug 15, 2005 Issue
Determining Prognosis for Patients with Terminal Cancer [Point-of-Care Guides]
An accurate prognosis enables patients with terminal cancer to make plans, put their affairs in order, and decide how they want to spend the time they have left. A prognosis also may help the primary care physician refer the patient for hospice care at a time when the patient would most benefit from the service.